Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repetitive Levosimendan Infusions for Advanced Chronic Heart Failure
DRKS00014953Phase 3Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial of levosimendan in chronic heart failure (CHF) (3 arms), sponsored by Medical University of Innsbruck. Started Jun 2018; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on DRKS00014953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014953.